139 related articles for article (PubMed ID: 1662279)
1. A new site for the activation of cardiac calcium channels defined by the nondihydropyridine FPL 64176.
Rampe D; Lacerda AE
J Pharmacol Exp Ther; 1991 Dec; 259(3):982-7. PubMed ID: 1662279
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
Zheng W; Rampe D; Triggle DJ
Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the effects of a new Ca2+ channel activator, FPL 64176, in GH3 cells.
Kunze DL; Rampe D
Mol Pharmacol; 1992 Oct; 42(4):666-70. PubMed ID: 1279375
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
Rampe D; Anderson B; Rapien-Pryor V; Li T; Dage RC
J Pharmacol Exp Ther; 1993 Jun; 265(3):1125-30. PubMed ID: 7685384
[TBL] [Abstract][Full Text] [Related]
5. Effects of McN-6186 on voltage-dependent Ca++ channels in heart and pituitary cells.
Rampe D; Skattebøl A; Triggle DJ; Brown AM
J Pharmacol Exp Ther; 1989 Jan; 248(1):164-70. PubMed ID: 2536427
[TBL] [Abstract][Full Text] [Related]
6. The L-type calcium channel current is increased by alpha-1 adrenoceptor activation in neonatal rat ventricular cells.
Liu QY; Karpinski E; Pang PK
J Pharmacol Exp Ther; 1994 Nov; 271(2):935-43. PubMed ID: 7965815
[TBL] [Abstract][Full Text] [Related]
7. Modulation of single channels underlying hippocampal L-type current enhancement by agonists depends on the permeant ion.
Tavalin SJ; Shepherd D; Cloues RK; Bowden SE; Marrion NV
J Neurophysiol; 2004 Aug; 92(2):824-37. PubMed ID: 15056682
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of L-type calcium channel blockade by lacidipine in guinea-pig ventricular myocytes.
Cerbai E; Giotti A; Mugelli A
Br J Pharmacol; 1997 Feb; 120(4):667-75. PubMed ID: 9051306
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II stimulates PGF(2 alpha)release in cultured neonatal rat ventricular myocytes via L-type calcium channels.
Oriji GK
Prostaglandins Leukot Essent Fatty Acids; 2001 Aug; 65(2):73-7. PubMed ID: 11545622
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of nifedipine induces up-regulation of functional calcium channels in rat myocardium.
Morgan PE; Aiello EA; Chiappe de Cingolani GE; Mattiazzi AR; Cingolani HE
J Mol Cell Cardiol; 1999 Oct; 31(10):1873-83. PubMed ID: 10525425
[TBL] [Abstract][Full Text] [Related]
11. Actions of the benzopyran compound terikalant on macroscopic currents in rat ventricular myocytes.
McLarnon JG; Xu R
J Pharmacol Exp Ther; 1995 Oct; 275(1):389-96. PubMed ID: 7562576
[TBL] [Abstract][Full Text] [Related]
12. Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644.
Usowicz MM; Gigg M; Jones LM; Cheung CW; Hartley SA
J Pharmacol Exp Ther; 1995 Nov; 275(2):638-45. PubMed ID: 7473149
[TBL] [Abstract][Full Text] [Related]
13. Toosendanin, a triterpenoid derivative, acts as a novel agonist of L-type Ca2+ channels in neonatal rat ventricular cells.
Li MF; Shi YL
Eur J Pharmacol; 2004 Oct; 501(1-3):71-8. PubMed ID: 15464064
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium red as an effective blocker of calcium and sodium currents in guinea-pig isolated ventricular heart cells.
Malécot CO; Bito V; Argibay JA
Br J Pharmacol; 1998 Jun; 124(3):465-72. PubMed ID: 9647469
[TBL] [Abstract][Full Text] [Related]
15. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
Kokubun S; Prod'hom B; Becker C; Porzig H; Reuter H
Mol Pharmacol; 1986 Dec; 30(6):571-84. PubMed ID: 2431263
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of cardiac T-type Ca channel blockade by amiloride.
Tytgat J; Vereecke J; Carmeliet E
J Pharmacol Exp Ther; 1990 Aug; 254(2):546-51. PubMed ID: 2166795
[TBL] [Abstract][Full Text] [Related]
17. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
[TBL] [Abstract][Full Text] [Related]
18. Expression of T-type Ca(2+) channels in ventricular cells from hypertrophied rat hearts.
Martínez ML; Heredia MP; Delgado C
J Mol Cell Cardiol; 1999 Sep; 31(9):1617-25. PubMed ID: 10471346
[TBL] [Abstract][Full Text] [Related]
19. Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.
Chahine M; Sculptoreanu A; Varma DR
Can J Physiol Pharmacol; 2003 Feb; 81(2):135-41. PubMed ID: 12710527
[TBL] [Abstract][Full Text] [Related]
20. The saponin monomer of dwarf lilyturf tuber, DT-13, reduces L-type calcium currents during hypoxia in adult rat ventricular myocytes.
Tao J; Wang H; Zhou H; Li S
Life Sci; 2005 Oct; 77(24):3021-30. PubMed ID: 15978637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
